Skip to main content

Markets collapse over impending trade war

The threat of an impending trade war with China sent the markets plummeting to close sharply lower with the Dow crashing 572 points to 23,932. Nasdaq collapsed 161 points to 6915.


On the upside


The Food and Drug Administration approved Pacira Pharmaceuticals' (Nasdaq: PCRX) supplemental new drug application to broaden the use of Exparel.


GOL Linhas (NYSE: GOL) reported an improved load factor for March 2018.


Supervalu (NYSE: SVU) is exploring a potential sale of the supermarket chain.

On the downside


NewLink Genetics (Nasdaq: NLNK) will review its clinical programs.


MannKind (Nasdaq: MNKD) priced its registered direct offering of 14 million common shares and warrants for a combined price of $2.00.


Investors locked in profits on Sunrun (Nasdaq: RUN).


In the broad market, declining issues outpaced advancers by a margin of nearly 4 to 1 on both the NYSE and on Nasdaq. The broader S&P 500 crashed 58 points to 2,604. Bitcoin slipped $2 to $6,605.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.